BIOGEN INC 52 Performance
| 09062XAD5 | 95.30 0.12 0.13% |
The bond shows a Beta (market volatility) of 0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BIOGEN's returns are expected to increase less than the market. However, during the bear market, the loss of holding BIOGEN is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BIOGEN INC 52 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for BIOGEN INC 52 investors. ...more
| Yield To Maturity | 6.215 |
BIOGEN |
BIOGEN Relative Risk vs. Return Landscape
If you would invest 9,925 in BIOGEN INC 52 on September 13, 2024 and sell it today you would lose (1,511) from holding BIOGEN INC 52 or give up 15.22% of portfolio value over 90 days. BIOGEN INC 52 is generating negative expected returns and assumes 1.8734% volatility on return distribution over the 90 days horizon. Simply put, 16% of bonds are less volatile than BIOGEN, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BIOGEN Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIOGEN's investment risk. Standard deviation is the most common way to measure market volatility of bonds, such as BIOGEN INC 52, and traders can use it to determine the average amount a BIOGEN's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1395
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 09062XAD5 |
Estimated Market Risk
| 1.87 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BIOGEN is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIOGEN by adding BIOGEN to a well-diversified portfolio.
About BIOGEN Performance
By analyzing BIOGEN's fundamental ratios, stakeholders can gain valuable insights into BIOGEN's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIOGEN has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIOGEN has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| BIOGEN INC 52 generated a negative expected return over the last 90 days |
Other Information on Investing in BIOGEN Bond
BIOGEN financial ratios help investors to determine whether BIOGEN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOGEN with respect to the benefits of owning BIOGEN security.